Fusion Pharmaceuticals Inc. Common Shares is a biopharmaceutical company that focuses on developing radiopharmaceuticals for the treatment of cancer. They use targeted alpha therapeutics to deliver radiation directly to tumor cells, maximizing efficacy and minimizing side effects. With an innovative approach and a strong pipeline, Fusion Pharmaceuticals is poised to make a significant impact in the field of oncology.
